Cleared Traditional

K954318 - ABBOTT AXSYM RUBELLA IGM ANTIBODY ASSAY (FDA 510(k) Clearance)

May 1996
Decision
242d
Days
Class 2
Risk

K954318 is an FDA 510(k) clearance for the ABBOTT AXSYM RUBELLA IGM ANTIBODY ASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II - Special Controls, product code LFX).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on May 14, 1996, 242 days after receiving the submission on September 15, 1995.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3510.

Submission Details

510(k) Number K954318 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 1995
Decision Date May 14, 1996
Days to Decision 242 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LFX — Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3510